Concepedia
Statistics
Publications
23
Citations
2.5K
H-Index
22
Active since
1989
Affiliations
Erasmus MC(Current)
Rotterdam University of Applied Sciences
Erasmus MC Cancer Institute
Erasmus University Rotterdam
University of Amsterdam
Antonius W.M. Boersma is an author at Erasmus MC specializing in oncology, medicine, and molecular oncology.
Publications per year
1989–2019
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump
Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 415 citations · Full text
Medicine, Molecular Biology, Oncology +11
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens, Anieta M. Sieuwerts, Marcel Smid et al. · Proceedings of the National Academy of Sciences · 2008 · 367 citations · Full text
Medicine, Cancer Biology, Oncology +17
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz, Marijn TM van Jaarsveld, Antoinette Hollestelle et al. · Breast Cancer Research · 2013 · 226 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
Marijn T. M. van Jaarsveld, Jozien Helleman, Antonius W.M. Boersma et al. · Oncogene · 2012 · 220 citations
Medicine, Molecular Biology, Oncology +16
Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin
Antonius W.M. Boersma, Kees Nooter, Robert Oostrum et al. · Cytometry · 1996 · 152 citations
Medicine, Cell Biology, Pharmacology +16
1–5 of 23